AC IMMUNE
AC Immune is a clinical stage Swiss-based biopharmaceutical company focused on neurodegenerative diseases with three product candidates in clinical trials. The Company designs, discovers and develops therapeutic and diagnostic products intended to prevent and modify diseases caused by misfolding proteins. AC Immune's two proprietary technology platforms create antibodies, small molecules and vaccines to address a broad spectrum of neurodegenerative indications
AC IMMUNE
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2003-01-01
Address:
Lausanne, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.acimmune.com
Total Employee:
51+
Status:
Active
Contact:
+41 21 345 91 21
Total Funding:
167.49 M USD
Technology used in webpage:
Euro Pound Sterling Microsoft Japanese Yen Microsoft Azure Akamai Hosted Comodo SSL Comodo PositiveSSL Comodo PositiveSSL Wildcard Microsoft Azure France Central Region
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Inovio Pharmaceuticals
Inovio is a biotech company focusing on bringing to market DNA medicines for diseases associated with HPV, cancer, and infectious diseases.
Current Advisors List
Board_member
Board_member
Advisor
Advisor
Board_member
Board_member
Advisor
Board_member
Current Employees Featured
Andreas Muhs CSO @ AC Immune
CSO
Marie Kosco-Vilbois Chief Scientific Officer @ AC Immune
Chief Scientific Officer
2019-01-01
Jean-Fabien Monin Chief Administrative Officer (CAO) @ AC Immune
Chief Administrative Officer (CAO)
2015-07-01
Andrea Pfeifer Co-Founder & CEO @ AC Immune
Co-Founder & CEO
2003-02-01
Wolfgang Barth Director of Development @ AC Immune
Director of Development
Founder
Stock Details
Investors List
Biotechnology Value Fund
Biotechnology Value Fund investment in Post-IPO Equity - AC Immune
Redmile Group
Redmile Group investment in Post-IPO Equity - AC Immune
StemPoint Capital
StemPoint Capital investment in Post-IPO Equity - AC Immune
Avidity Partners
Avidity Partners investment in Post-IPO Equity - AC Immune
Dietmar Hopp
Dietmar Hopp investment in Series E - AC Immune
dievini Hopp Biotech Holding
dievini Hopp Biotech Holding investment in Series D - AC Immune
Key Employee Changes
Date | New article |
---|---|
2023-12-01 | AC Immune makes interim CFO Christopher Roberts permanent |
2023-07-26 | AC Immune names new chief medical officer |
Official Site Inspections
http://www.acimmune.com Semrush global rank: 3.61 M Semrush visits lastest month: 3.54 K
- Host name: od-c8532b.infomaniak.ch
- IP address: 83.166.155.136
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich

More informations about "AC Immune"
Who is AC Immune? A cutting-edge company with a …
AC Immune is a clinical-stage biopharmaceutical company emerging as a global leader in precision medicine to diagnose, treat and prevent neurodegenerative diseases.See details»
AC Immune - Crunchbase Company Profile & Funding
AC Immune is a clinical stage Swiss-based biopharmaceutical company focused on neurodegenerative diseases with three product candidates in clinical trials.See details»
Our Teams - AC Immune SA
AC Immune’s leadership team combines a proven track record in entrepreneurial management and world-class scientific thought leadership. The team is committed to excellence and is …See details»
AC Immune - Overview, News & Similar companies | ZoomInfo.com
Dec 2, 2023 View AC Immune (www.acimmune.com) location in Vaud, Switzerland , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
AC Immune S.A. (ACIU-Q) Profile - The Globe and Mail
See the company profile for AC Immune S.A. (ACIU-Q) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
Annual Report 2022 - AC Immune SA
The World Health Organization recognizes dementia as a global public health priority. Worldwide, there is a new case of dementia every 3 seconds, with an estimated global patient population …See details»
AC Immune - LinkedIn
AC Immune SA is a clinical-stage biopharmaceutical company and a global leader in precision prevention for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and ...See details»
2021 Annual Report - AC Immune SA
As our organization evolves and grows, our Board of Directors continues to be reinforced. Each member brings a wealth of experience and knowledge well suited to our Company and we …See details»
AC Immune SA – Swiss Biotech
AC Immune SA is a clinical-stage biopharma that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and …See details»
Contacts & Resources - AC Immune SA
Media inquiries:communications@acimmune.com: Phone: +41 21 345 91 21 : Fax: +41 21 345 91 20 . CONTACT FORM. Name. Email. Subject. Comments. Leave this field blank . E-MAIL …See details»
AC Immune Reports Positive Interim Results from Phase 2
Nov 14, 2024 Head of Investor Relations & Corporate Communications Gary Waanders, Ph.D., MBA AC Immune Phone: +41 21 345 91 91 Email: gary.waanders@acimmune.com U.S. …See details»
Pioneering precision medicine - AC Immune SA
Precision medicine is an approach to treating complex diseases. Successfully used in oncology, AC Immune is pioneering precision medicine approaches to address Alzheimer’s and other …See details»
AC Immune Holds Annual General Meeting of Shareholders
Jun 24, 2022 AC Immune SA is a clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including …See details»
Careers - AC Immune SA
Our Team focuses on growth, brand, customer satisfaction, safety and profitability alike, without compromising on ethics and fairness. We prioritize our Team’s needs, support colleagues …See details»
AC Immune SA (ACIU) Stock Price, News, Quote & History - Yahoo …
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative …See details»
Press Release Details - ir.acimmune.com
Sep 17, 2024 About AC Immune SA AC Immune SA is a clinical-stage biopharmaceutical company and a global leader in precision prevention for neurodegenerative diseases, …See details»
Our first- and best-in-class therapeutic & diagnostic candidates
Future treatment paradigms will combine different therapies at various stages of a disease to engage the underlying co-pathologies. Our suite of non-invasive diagnostic programs targeting …See details»
Press Release Details - AC Immune SA
AC Immune SA is clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s disease, …See details»
AC Immune's Robust Pipeline focused on neurodegenerative …
Based on our SupraAntigen® and Morphomer® technology platforms, we are advancing one of the industry’s broadest and most diverse clinical-stage pipelines focused on …See details»